SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-005476
Filing Date
2017-03-29
Accepted
2017-03-29 08:00:19
Documents
4
Period of Report
2017-03-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtvt-8k_20170329.htm 8-K 23346
2 EX-99.1 vtvt-ex991_79.htm EX-99.1 4104
3 EX-99.2 vtvt-ex992_57.htm EX-99.2 6215
4 GRAPHIC gwtvswlb1hmt000001.jpg GRAPHIC 2685623
  Complete submission text file 0001564590-17-005476.txt   3732992
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 17720672
SIC: 2834 Pharmaceutical Preparations